Skip to main
CDIO
CDIO logo

CDIO Stock Forecast & Price Target

CDIO Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Cardio Diagnostics Holdings Inc demonstrates strong potential for growth, particularly as its revenue could exceed expectations if it ramps up more swiftly than anticipated. The company is actively expanding its market reach by working on obtaining broader reimbursement for its innovative tests and has established a new operations hub featuring a CLIA-certified, high-complexity laboratory, which is likely to enhance efficiency and reduce costs. While Cardio Diagnostics has successfully secured additional capital for operational needs, concerns remain about future access to funding on favorable terms, highlighting the importance of monitoring its financial strategy moving forward.

Bears say

Cardio Diagnostics Holdings Inc. has not achieved profitability since its inception, incurring operating losses annually and lacking a significant operating history, which raises concerns about its long-term financial viability. The company's dependence on regulatory approvals introduces additional risks, as unforeseen regulatory changes could adversely affect revenue and escalate costs. Moreover, potential disruptions in the supply chain or increases in raw material prices could further jeopardize the firm's business operations and overall financial health.

CDIO has been analyzed by 2 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cardio Diagnostics Holdings In and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cardio Diagnostics Holdings In (CDIO) Forecast

Analysts have given CDIO a Buy based on their latest research and market trends.

According to 2 analysts, CDIO has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cardio Diagnostics Holdings In (CDIO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.